Managing Behçet’s disease: An update on current and emerging treatment options

References

• KaklamaniVGVaiopoulosGKaklamanisPGBehçet’s diseaseSemin Arthritis Rheum19982741972179514126
   PubMed Web of Science ®Google Scholar
• YaziciHFreskoIYurdakulSBehçet’s syndrome: disease manifestations, management, and advances in treatmentNat Clin Pract Rheumatol20073314815517334337
   PubMedGoogle Scholar
• DilsenNHistory and development of Behçet’s diseaseRev Rhum Engl Ed1996637–85125198896069
   PubMedGoogle Scholar
• SakaneTTakenoMSuzukiNInabaGBehçet’s diseaseN Engl J Med1999341171284129110528040
   PubMed Web of Science ®Google Scholar
• IdilAGurlerABoyvatAThe prevalence of Behçet’s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, TurkeyOphthalmic Epidemiol20029532533112528917
   PubMed Web of Science ®Google Scholar
• GulAInancMOcalLAralOKoniceMFamilial aggregation of Behçet’s disease in TurkeyAnn Rheum Dis200059862262510913059
   PubMed Web of Science ®Google Scholar
• BaranathanVStanfordMRVaughanRWThe association of the PTPN22 620W polymorphism with Behçet’s diseaseAnn Rheum Dis200766111531153317660222
   PubMed Web of Science ®Google Scholar
• TakenoMKariyoneAYamashitaNExcessive function of peripheral blood neutrophils from patients with Behçet’s disease and from HLA-B51 transgenic miceArthritis Rheum19953834264337880197
   PubMed Web of Science ®Google Scholar
• Criteria for diagnosis of Behçet’s diseaseInternational Study Group for Behçet’s DiseaseLancet19903358697107810801970380
   PubMed Web of Science ®Google Scholar
• ChangHKCheonKSThe clinical significance of a pathergy reaction in patients with Behçet’s diseaseJ Korean Med Sci200217337137412068142
   PubMed Web of Science ®Google Scholar
• AkayNBoyvatAHeperAOBehçet’s disease-like presentation of bullous pyoderma gangrenosum associated with Crohn’s diseaseClin Exp Dermatol200631338438616681583
   PubMed Web of Science ®Google Scholar
• Graham-BrownRASarkanyIFailure of colchicine and fibrinolytic therapy in Behçet’s diseaseClin Exp Dermatol19805187927398131
   PubMed Web of Science ®Google Scholar
• AktulgaEAltacMMuftuogluAA double blind study of colchicine in Behçet’s diseaseHaematologica19806533994026778795
   PubMed Web of Science ®Google Scholar
• YurdakulSMatCTuzunYA double-blind trial of colchicine in Behçet’s syndromeArthritis Rheum200144112686269211710724
   PubMed Web of Science ®Google Scholar
• YasuiKOhtaKKobayashiMAizawaTKomiyamaASuccessful treatment of Behçet disease with pentoxifyllineAnn Intern Med1996124108918938610918
   PubMed Web of Science ®Google Scholar
• ConvitJGoihman-YahrMRondon-LugoAJEffectiveness of dapsone in Behçet’s diseaseBr J Dermatol198411156296306498097
   PubMed Web of Science ®Google Scholar
• LinPLiangGBehçet disease: recommendation for clinical management of mucocutaneous lesionsJ Clin Rheumatol200612628228617149058
   PubMed Web of Science ®Google Scholar
• MasudaKNakajimaAUrayamaANakaeKKogureMInabaGDouble-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet’s diseaseLancet198918647109310962566048
   PubMed Web of Science ®Google Scholar
• HatemiGSilmanABangDEULAR recommendations for the management of Behçet diseaseAnn Rheum Dis200867121656166218245110
   PubMed Web of Science ®Google Scholar
• AdlerYDMansmannUZouboulisCCMycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet’s diseaseDermatology2001203432232411752821
   PubMed Web of Science ®Google Scholar
• KappenJHMensinkPBLesterhuisWMycophenolate sodium: effective treatment for therapy-refractory intestinal Behçet’s disease, evaluated with enteroscopyAm J Gastroenterol2008103123213321419086980
   PubMed Web of Science ®Google Scholar
• MelilloNSangleSStanfordMRAndrewsTCD’CruzDPLow-dose intra-venous cyclophosphamide therapy in a patient with neurological complications of Behçet’s diseaseClin Rheumatol20072681365136717063282
   PubMed Web of Science ®Google Scholar
• AktoguSErerOFUrpekGSoyOTibetGMultiple pulmonary arterial aneurysms in Behçet’s disease: clinical and radiologic remission after cyclophosphamide and corticosteroid therapyRespiration200269217818111961435
   PubMed Web of Science ®Google Scholar
• CalguneriMErtenliIKirazSErmanMCelikIEffect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet’s diseaseDermatology199619221251288829493
   PubMed Web of Science ®Google Scholar
• CalguneriMKirazSErtenliIBenekliMKaraarslanYCelikIThe effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet’s disease. A randomized clinical trialArthritis Rheum19963912206220658961912
   PubMed Web of Science ®Google Scholar
• Al-WaizMMSharquieKEMHAQHayaniRKColchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative studyDermatol Online J2005113316409899
   PubMedGoogle Scholar
• FeronEJRothovaAvan HagenPMBaarsmaGSSuttorp-SchultenMSInterferon-alpha 2b for refractory ocular Behçet’s diseaseLancet1994343891014287910903
   PubMed Web of Science ®Google Scholar
• AlpsoyEDurusoyCYilmazEInterferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind studyArch Dermatol2002138446747111939808
   PubMed Web of Science ®Google Scholar
• KotterIGunaydinIZierhutMStubigerNThe use of interferon alpha in Behçet disease: review of the literatureSemin Arthritis Rheum200433532033515079763
   PubMed Web of Science ®Google Scholar
• SfikakisPPKaklamanisPHElezoglouAInfliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet diseaseAnn Intern Med2004140540440614996689
   PubMed Web of Science ®Google Scholar
• MelikogluMFreskoIMatCShort-term trial of etanercept in Behçet’s disease: a double blind, placebo controlled studyJ Rheumatol20053219810515630733
   PubMed Web of Science ®Google Scholar
• van LaarJAMissottenTvan DaelePLJamnitskiABaarsmaGSvan HagenPMAdalimumab: a new modality for Behçet’s disease?Ann Rheum Dis200766456556617124248
   PubMed Web of Science ®Google Scholar
• MushtaqBSaeedTSitunayakeRDMurrayPIAdalimumab for sight-threatening uveitis in Behçet’s diseaseEye200721682482516601736
   PubMed Web of Science ®Google Scholar
• BotsiosCSfrisoPFurlanAPunziLDinarelloCAResistant Behçet disease responsive to anakinraAnn Intern Med2008149428428618711165
   PubMed Web of Science ®Google Scholar
• Borhani HaghighiASafariATocilizumab may be a potential addition to our weapons against neuro-Behçet’s diseaseMed Hypotheses200871115615718304751
   PubMed Web of Science ®Google Scholar